Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction.

NCT03166241 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Adverse Cutaneous Reaction to Alternative Medical Therapy

Interventions

DIAGNOSTIC_TEST: serum interleukin 21
DIAGNOSTIC_TEST: Complete Blood Picture
DIAGNOSTIC_TEST: Liver function test
DIAGNOSTIC_TEST: Random Blood Sugar
DIAGNOSTIC_TEST: Erythrocyte Sedimentation Rate
DIAGNOSTIC_TEST: Kidney function tests

Sponsor

Assiut University